Jonathan Barratt, MD, consultant nephrologist and professor of renal medicine, University of Leicester and John Walls Renal Unit, Leicester, provides a comprehensive overview of IgA nephropathy. Professor Barratt also discusses updates on new treatments for patients with IgA nephropathy.
Sean Converse was diagnosed with IgA nephropathy in late 2022 following an acute upper respiratory illness. Sean discusses challenges and his experience with IgA nephropathy.
Jennifer Vaughan, APRN, and Kenneth K. Afenya, MD, of Lex Kidney Care, Lexington, Kentucky, discuss the basics of IgA nephropathy, including signs and symptoms, as well as epidemiology…
Jonathan Barratt, MD, University of Leicester, UK, discusses the need for improved continuity of care for patients with IgA nephropathy. Professor Barratt notes that the rarity of the…
This video discusses the risk factors for IgA nephropathy, a disease with no single known cause. While anyone can develop it, certain groups are at higher risk, including…
Dawn J. Caster, MD, FASN, associate professor of medicine, Division of Nephrology & Hypertension, University of Louisville School of Medicine, Louisville, Kentucky, discusses IgA nephropathy, including when to…
Sean Hashmi, MD, a board-certified nephrologist and obesity medicine specialist, for his weekly Friday night live sessions from Los Angeles. In this episode, Dr. Hashmi delves into IgA…
Explore IgA nephropathy, a rare autoimmune kidney disease where the IgA protein builds up in the kidneys. Normally, IgA helps protect against infections, but in this condition, it…
In this heartfelt video, four different patients share their journies with IgA nephropathy, kidney failure, and the eventual need for a transplant. Initially unaware of their conditions, they…
Obi Umeh, MD, MSc, VP, Franchise Global Program Leader at Takeda, discusses interim results from a study investigating mezagitamab for the treatment of patients with IgA nephropathy. This…
Professor Jonathan Barratt, head of the Renal Research Group within the College of Life Sciences at the University of Leicester, discusses the latest advancements in the treatment of…
